Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
1h
Zacks Investment Research on MSNWhy Cardinal Health (CAH) is a Top Value Stock for the Long-TermTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
Cardinal Health's stock has surged 133% since May 2022, but its long-term chart reveals a history of prolonged correction.
17h
Zacks.com on MSNCardinal Health (CAH) Stock Drops Despite Market Gains: Important Facts to NoteCardinal Health (CAH) concluded the recent trading session at $132.75, signifying a -0.35% move from its prior day's close.
Cardinal Health outpaces S&P 500 with strong growth in specialty pharmaceuticals. Read why CAH stock has limited upside ...
Cardinal Health Inc. closed 0.34% below its 52-week high of $133.67, which the company reached on March 21st.
StockStory.org on MSN5d
Healthcare Providers & Services Stocks Q4 Teardown: Cardinal Health (NYSE:CAH) Vs The RestQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
5d
Barchart on MSNCardinal Health Stock: Is CAH Outperforming the Healthcare Sector?Cardinal Health, Inc. (CAH), headquartered in Dublin, Ohio, is a leading global healthcare solutions provider specializing in pharmaceutical distribution, medical and laboratory products, and ...
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results